IPharma collaborates with your provider to assess your eligibility, discuss treatment goals, and ensure the medication is tailored to you
1 Standards of Therapy The approach to management of overweight and obesity is multi-pronged, and includes modification of physical activity and behaviour, in addition to medical nutrition therapy
In the STEP clinical trials, participants who combined semaglutide with lifestyle interventions lost up to 17.4 percent of baseline body weight, compared to 14.9 percent for those with less intensive behavioral support
To begin your semaglutide journey, simply follow this brief guide: Hit the Enroll Now option
(2024, July 26)
Behavioral and Lifestyle Factors Improvement in mood may lead patients to eat more social meals, snack more often, or enjoy foods previously avoided, indirectly causing weight gain